Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Cytek Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −1 vs. Q1 2023
- Shares held
- 77.0M
- +8.53M (+12.4%) vs. Q1 2023
- Total value
- $657.9M
- +$28.3M (+4.5%) vs. Q1 2023
- New holders
- 24
- 51 more added
- Sold out
- 25
- 18 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTKB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $361.0M |
| Q1 2026 | 165 | $371.8M |
| Q4 2025 | 155 | $414.3M |
| Q3 2025 | 153 | $277.4M |
| Q2 2025 | 158 | $270.0M |
| Q1 2025 | 161 | $310.8M |
| Q4 2024 | 153 | $501.4M |
| Q3 2024 | 136 | $415.3M |
| Q2 2024 | 129 | $425.1M |
| Q1 2024 | 125 | $540.9M |
| Q4 2023 | 105 | $719.9M |
| Q3 2023 | 107 | $427.7M |
| Q2 2023 | 101 | $657.9M |
| Q1 2023 | 102 | $629.6M |
| Q4 2022 | 103 | $654.1M |
| Q3 2022 | 88 | $898.5M |
| Q2 2022 | 85 | $567.8M |
| Q1 2022 | 74 | $514.5M |
| Q4 2021 | 52 | $571.9M |
| Q3 2021 | 54 | $733.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Cytek Biosciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 15,127,505 | $129.2M | 0.00% | +6,840,258+82.5% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,289,534−100.0% | Sold out |
| Blue Water Life Science Advisors, LLC | 0 | $0 | 0.00% | −1,109,000−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −498,448−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −353,500−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −137,838−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −133,249−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −128,574−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −123,997−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −119,770−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −106,841−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −99,089−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −78,392−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −35,172−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −31,226−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −30,773−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −25,679−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −18,790−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −18,172−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,227−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −13,581−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −13,267−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −10,625−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −346−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −68−100.0% | Sold out |